References
Trey C, Davidson CS (1970) The management of fulminant hepatic failure. In: Popper H, Schaffner F (eds) Progress in liver disease, vol III. Grune and Stratton, New York, pp 282–298
Gimson AES, Canalese J, Hughes RD, Williams R (1980) Management of fulminant hepatic failure. Update 6: 1161–1170
Chang MY, Campbell WG Jr (1975) Fatal infectious mononucleosis: association with liver necrosis and herpes like virus particles. Arch Pathol 99: 185–191
Henson DE, Crimley PM, Strane AJ (1974) Postnatal cytomegalovirus hepatitis: an autopsy and liver biopsy study. Hum Pathol 5:93
Francis TI, Osuntokum BO, Kemp GE (1972) Fulminant hepatitis due to herpes hominis in an adult human. Am J Gastroenterol 57:329–332
Hanid MA, Silk DBA, Williams R (1978) Prognostic value of the oculovestibular reflex in fulminant hepatic failure. Br Med J 1:1029–1030
Canalese J, Gimson AES, Davis M, Williams R (1981) Factors contributing to mortality in paracetamol induced hepatic failure. Br Med J 1:199–201
Gazzard BG, Portmann B, Murray-Lyon IM, Williams R (1975) Causes of death in fulminant hepatic failure and relationship to quantitative histological assessment of parenchymal damage. Q J Med 44:615–626
Wyke RJ, Rajkovic IA, Eddleston ALWF, Williams R (1980), Detective opsonisation and complement deficiency in serum from patients with fulminant hepatic failure. Gut 21:643–649
Yousif-Kadaru AM, Wyke RJ, Rajkovic IA, Eddleston ALWF, Williams R (1980) Serum factors affecting movement of leucocytes in patients with fulminant hepatic failure. Clin Sci 58:14
Bailey RJ, MacDougall BRD, Williams R (1976) A controlled trial of the H2 antagonists in prophylaxis of bleeding from gastrointestinal tract erosions in fulminant hepatic failure. Gut 17:389
MacDougall BRD, Bailey RJ, Williams R (1977) H2 receptor antagonists and antacids in the presentation of acute upper gastrointestinal haemorrhage in fulminant hepatic failure. Lancet 1:617–619
Wilkinson SP, Moodie H, Arroyo VA, Williams R (1977) Frequency of renal impairment in paracetamol overdose compared with other causes of acute liver damage. J Clin Pathol 30:141–145
Record CO, Iles RA, Cohen RD, Williams R (1975) Acid-base and metabolic disturbances in fulminant hepatic failure. Gut 16:144–149
Wilkinson SP, Blendis LM, Williams R (1974) Frequency and type of renal and electrolyte abnormalities in fulminant hepatic failure. Br Med J 1:186–189
Wilkinson SP, Arroyo VA, Moodie H, Blendis LM, Williams R (1976) Abnormalities of sodium excretion and other disorders or renal function in fulminant hepatic failure. Gut 17:501–505
Alam AN, Wilkinson SP, Poston L, Moodie H, Williams R (1977) Intracellular electrolyte abnormalities in fulminant hepatic failure. Gastroenterology 72:914–919
Weston MJ, Talbot K, Howarth PJH, Mant AK, Capildeo R, Williams R (1976) Frequency of arrythmias and other cardiac abnormalities in fulminant hepatic failure. Br Heart J 38:1179–1182
Trewby PN, Warren R, Contini S, et al. (1978) Incidence and pathophysiology of pulmonary oedema in fulminant hepatic failure. Gastroenterology 74:859–865
Silk DBA, Hanid MA, Trewby PN, et al. (1977) Treatment of fulminant hepatic failure by polyacrylonitrile haemodialysis. Lancet 2:1–3
Hanid MA, Davis M, Mellon PJ, et al. (1980) Clinical monitoring intracranial pressure in fulminant hepatic failure. Gut 21:866–869
Opolon P, Lavallard MC, Huguet CI, et al. (1976) Haemodialysis versus cross haemodialysis in experimental hepatic coma. Surg Gynaecol Obstet 142:845–854
Bloch P, Delosme ML, Rapin JR, Boschat M, Opolon P (1978) Reversible modifications of brain neurotransmitters in experimental acute hepatic coma. Surg Gynaecol Obstet 146:551–558
Hughes RD, Cochrane AMG, Thomson AD, Murray-Lyon IM, Williams R (1976) The cytotoxicity of plasma from patients with acute hepatic failure to isolated rabbit hepatocytes. Br J Exp Pathol 57:348–353
Weston MJ, Langley PJ, Rubin MH, Hanid MA, Mellon PJ, Williams R (1977) Platelet function in fulminant hepatic failure and effect of charcoal haemoperfusion. Gut 18:897–902
Gimson AES, Langley PJ, Hughes RD, et al. (1980) Prostacyclin to prevent platelet activation during charcoal haemoperfusion. Lancet 1:173–174
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Braude, S., Gimson, A.E.S. & Williams, R. Progress in the management of fulminant hepatic failure. Intensive Care Med 7, 101–103 (1981). https://doi.org/10.1007/BF01738610
Issue Date:
DOI: https://doi.org/10.1007/BF01738610